NCT02889302View on ClinicalTrials.gov

An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373

24 weeks

DRUG

Placebo

24 weeks

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY